Idera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

IDRA 3.29 -0.03 (-1.05%)
price chart
Why Idera Pharmaceuticals Inc. Shares Jumped
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Idera Pharmaceuticals Inc. Stock Downgraded (IDRA)
Idera says drug safe, well tolerated in psoriasis study  Chicago Tribune (blog)
Related articles »  
Idera Pharmaceuticals Inc (NASDAQ:IDRA) Shares Jump On Widespread ...
Dallas, Texas, 04/23/2014 (ustrademedia) - Idera Pharmaceuticals Inc (NASDAQ:IDRA) is a $273 million biotech company. The company recently reported positive results from its experimental drug that could give hope to B-cell lymphoma patients.
Biotech Gainers: Geron Corporation (NASDAQ:GERN), Idera Pharmaceuticals ...  Gaining Green
Healthcare stocks' rally: Cytokinetics (CYTK), Ariad Pharmaceuticals ...  Markets Emerging
Related articles »  
Idera Pharmaceutical Up After Market; Big Moves in Agios and Idenix
Idera Pharmaceuticals Inc (IDRA) was up over 4.42% in after-hours trading yesterday after data was released that shows its Toll-like Receptor (TLR) antagonist, IMO-8400, is able to inhibit the spread and survival of B-cell lymphoma cells that carry the ...
Idera Pharmaceuticals, Inc. Bouncing on Phase 2 Success
Idera Pharmaceuticals' (NASDAQ: IDRA ) stock market rollercoaster ride left it partially recovered from its 25% plunge just over a week ago upon FDA approval of a competing product developed by Celgene (NASDAQ: CELG ) .
Better Psoriasis Treatments Needed Worldwide, Panel Says  Guardian Liberty Voice
Related articles »  
Idera Pharmaceuticals, Inc. (IDRA) in Focus: Stock Stock Surges 17.8%
If you have any questions, please email customer support at or call 800-767-3771 ext. 9339. Idera Pharmaceuticals, Inc. (IDRA - Snapshot Report) was a big mover last session, as the company saw its shares surge nearly 18% on the day.
Related articles »  
Micro-cap Losers: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Travelzoo Inc ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) recently presented its new pre- clinical data that demonstrates the ability of the TLR or Toll-like receptor antagonist, IMO-8400, for inhibiting survival and the proliferation of the B-cell lymphoma cells that ...
Today's Dead Cat Bounce Stock Is Idera Pharmaceuticals (IDRA)
Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.
Related articles »  
Intraday Movers: Rexahn Pharmaceuticals, Inc. (RNN), Windstream Holdings ...
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) increased 4.00% and closed at $1.04 in the last trading session with the overall traded volume of 4.81 million shares, versus the average volume of 5.87 million shares.
Investor's Alert - Rexahn Pharmaceuticals, Inc. (RNN), Windstream Holdings ...
Stamford, Connecticut - 23th April 2014 - (Techsonian) - Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) recently declared that it was two poster presentations at the 2014 American Association for Cancer Research Annual Meeting.
Related articles »  
Stocks Under Consideration � RadioShack Corporation (RSH), Rexahn ...
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, reported promising preclinical results for RX-21101, the Company's first development candidate ...
Related articles »